The renal effects of nonsteroidal anti-inflammatory drugs summary and recommendations

B cells (B Lymphocytes) are cells in the bone marrow which develop into plasma cells that produce antibodies. Rituximab is an artificially produced antibody that attacks B lymphocytes, a single dose (or 2 doses) lowering B cell counts for many months. This has only slow effects on antibody levels, as the plasma cells that are producing antibodies are not targeted by the antibody. However Rituximab and other B cell antibodies seems to reduce autoantibody levels slowly in some conditions, and can also help in some other autoimmune diseases, even when autoantibodies aren't obviously the problem. 

The renal effects of nonsteroidal anti-inflammatory drugs summary and recommendations

the renal effects of nonsteroidal anti-inflammatory drugs summary and recommendations

Media:

the renal effects of nonsteroidal anti-inflammatory drugs summary and recommendationsthe renal effects of nonsteroidal anti-inflammatory drugs summary and recommendationsthe renal effects of nonsteroidal anti-inflammatory drugs summary and recommendationsthe renal effects of nonsteroidal anti-inflammatory drugs summary and recommendationsthe renal effects of nonsteroidal anti-inflammatory drugs summary and recommendations